@RIP_GOP1234 @sparky6871 There are no combo trials using -L, rather UCLA's own, which is different. As for the PhIII, ''After surgery and chemoradiotherapy, patients were randomized (2:1) to receive temozolomide plus DCVax-L (n = 232) or temozolomide and
200 followers
70 followers
@CaliLerone @PopsWhisky @mattkolleck1 @Nina_kd @d_stock07734 From this: ''The primary endpoint was progression free survival (PFS); the secondary endpoint was overall survival (OS).'' https://t.co/n6nL0iLpc7 They ran a randomised trial. The idea is to sho
373 followers
@smith348572 As a matter of fact, all the C-suite of $NVCR started selling after the first results on DCVax-L were published on May 29, 2018. https://t.co/HxvuSsItHE
6,188 followers
RT @AXuring2: @Longing4L @hoffmann6383 Way higher indeed! Don't forget that $NWBO's SP prior to May 10 was already at an artificially suppr…